ID   KKK-D049
AC   CVCL_XD17
SY   KKK-D049H3
DR   JCRB; JCRB1771
DR   Wikidata; Q94340042
RX   PubMed=31126020;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Established from a third generation xenograft established in BALB/c Rag-2-/-/Jak3-/- mice.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB; PubMed=31126020
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 13 (JCRB)
ST   D16S539: 13,14 (PubMed=31126020)
ST   D19S433: 13,15.2
ST   D18S51: 11
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 12,17
ST   FGA: 23,24.2
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
RX   PubMed=31126020; DOI=10.3390/cells8050496;
RA   Vaeteewoottacharn K., Pairojkul C., Kariya R., Muisuk K., Imtawil K.,
RA   Chamgramol Y., Bhudhisawasdi V., Khuntikeo N., Pugkhem A.,
RA   Saeseow O.-T., Silsirivanit A., Wongkham C., Wongkham S., Okada S.;
RT   "Establishment of highly transplantable cholangiocarcinoma cell lines
RT   from a patient-derived xenograft mouse model.";
RL   Cells 8:496.1-496.15(2019).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//